New use of old drug reduces risk of kidney cancer returning

Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third, according to new research.

Mon, 11 Jul 2022
Kidney Cancer

The findings from the Phase III trial are presented today at the European Association of Urology congress (EAU21).

There is a high risk of kidney cancer returning, following surgery to remove tumours, but there is currently no treatment to help prevent this.